India Gets First Alzheimer’s Disease-Modifying Therapy (Donanemab) and First Subcutaneous Lung Cancer Immunotherapy
Two notable medical launches have taken place in India. Donanemab, sold under the brand name Lormalzi, has been introduced as the country’s first disease-modifying therapy for Alzheimer’s disease, a treatment that target...